Results 11 to 20 of about 166,471 (381)

Remission induction in acute myeloid leukemia [PDF]

International Journal of Hematology, 2012
Inducing a complete remission (CR) in patients with acute myeloid leukemia is a prerequisite to long-term disease control with subsequent post-remission consolidation chemotherapy or allogeneic hematopoietic stem cell transplantation. The use of 7 days of infusional cytarabine and 3 days of daunorubicin or idarubicin (7 + 3) has become the standard of ...
Eytan M. Stein, Martin S. Tallman
openaire   +5 more sources

VAD chemotherapy as remission induction for multiple myeloma [PDF]

British Journal of Cancer, 1995
A total of 142 patients with multiple myeloma received VAD as remission induction therapy. Seventy-five were previously untreated and 67 had relapsed (31) or refractory disease (36). Vincristine (total dose 1.6 mg) was infused with doxorubicin 36 mg m-2 by continuous ambulatory pump over 4 days. In addition, oral dexamethasone 40 mg day-1 was given for
L Fitzsimmons, R.I. Young, Heather Anderson, J. H. Scarffe, G. R. Morgenstern, Malcolm R Ranson, D Ryder, GS Wieringa   +7 more
openaire   +3 more sources

Comparison of early versus late addition of granulocyte and monocyte adsorption for incomplete remission induction in ulcerative colitis. [PDF]

JGH Open
Background and aim Ulcerative colitis (UC) is characterized by repeated relapse and remission. Because no fundamental therapeutic strategy has been established, the treatment goal is generally to maintain the remission phase for a long period after rapid
Tominaga K, Kanazawa M, Watanabe S, Tanaka T, Kojimahara S, Masuyama S, Abe K, Kanamori A, Yamamiya A, Sugaya T, Goda K, Fujita Y, Yoshihara S, Haruyama Y, Irisawa A.   +14 more
europepmc   +2 more sources

Coherent enhancement of optical remission in diffusive media [PDF]

Proc. Natl. Acad. Sci. U.S.A. Vol. 119, e2207089119 (2022), 2022
From the earth's crust to the human brain, remitted waves are used for sensing and imaging in a diverse range of diffusive media. Separating the source and detector increases the penetration depth of remitted light, yet rapidly decreases the signal strength, leading to a poor signal-to-noise ratio.
arxiv   +1 more source

Serum ferritin is a good indicator for predicting the efficacy of adult HLH induction therapy

Annals of Medicine, 2022
Background: Hemophagocytic lymphohistiocytosis (HLH) is a rare clinical syndrome with a high mortality rate. There is no biomarker to predict the early therapeutic response.
Zhengjie Hua, Lingbo He, Ruoxi Zhang, Menghan Liu, Zhao Wang, Yini Wang   +5 more
doaj   +1 more source

Remission after Six Months of Induction Immunosuppressive Treatment with Mycofenolate Mofetil and Prednisolone in Patients with Lupus Nephritis: A Descriptive Cross-sectional Study

Journal of Nepal Medical Association, 2021
Introduction: Treatment of lupus nephritis consists of six months of induction immunosuppression followed by years of maintenance immunosuppression.
Shailendra Shrestha, Rahul Yadav
doaj   +1 more source

A case of regression of atypical dense deposit disease without C3 deposition in a child [PDF]

Korean Journal of Pediatrics, 2010
Dense deposit disease (DDD) is a rare disorder characterized by the deposition of abnormal electron-dense material within the glomerular basement membrane of the kidneys. The diagnosis is made in most patients between 5 and 15 years of age, and within 10
Min Sun Kim, Pyoung Han Hwang, Mung Jae Kang, Dae-Yeol Lee   +3 more
doaj   +1 more source

Probiotics for induction of remission in Crohn's disease

Cochrane Database of Systematic Reviews, 2020
Crohn's disease (CD) is a chronic inflammatory disorder of the gastrointestinal tract, in which the pathogenesis is believed to be partly influenced by the gut microbiome. Probiotics can be used to manipulate the microbiome and have therefore been considered as a potential therapy for CD.
Limketkai, Berkeley N, Akobeng, Anthony K, Gordon, Morris, Adepoju, Akinlolu Adedayo   +3 more
openaire   +4 more sources

Glutamine for induction of remission in Crohn's disease [PDF]

Cochrane Database of Systematic Reviews, 2016
Crohn's disease is a chronic relapsing condition of the alimentary tract with a high morbidity secondary to bowel inflammation. Glutamine plays a key role in maintaining the integrity of the intestinal mucosa and has been shown to reduce inflammation and disease activity in experimental models of Crohn's disease.To evaluate the efficacy and safety of ...
Akobeng, Anthony, Elawad, M, Gordon, Morris   +2 more
openaire   +3 more sources

Methotrexate for induction of remission in ulcerative colitis [PDF]

Cochrane Database of Systematic Reviews, 2014
Ulcerative colitis (UC) is a chronic inflammatory bowel disease. Corticosteroids and 5-aminosalicylates are the most commonly used therapies. However, many patients require immunosuppressive therapy for steroid-refractory and steroid-dependent disease.
John K MacDonald, John Wd McDonald, Yongjun Wang, Nilesh Chande   +3 more
openaire   +3 more sources